Sangamo Therapeutics
SGMO
#8849
Rank
โ‚น13.66 B
Marketcap
โ‚น40.61
Share price
-1.98%
Change (1 day)
-74.94%
Change (1 year)

Market capitalization of Sangamo Therapeutics (SGMO)

Market cap: โ‚น13.66 Billion

As of December 2025 Sangamo Therapeutics has a market cap of โ‚น13.66 Billion. This makes Sangamo Therapeutics the world's 8849th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Sangamo Therapeutics from 2000 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚น13.66 B-70.17%
2024โ‚น45.82 B471.25%
2023โ‚น8.02 B-81.16%
2022โ‚น42.58 B-47.64%
2021โ‚น81.32 B-49.62%
2020โ‚น161.42 B133.2%
2019โ‚น69.22 B-15.61%
2018โ‚น82.02 B-7.32%
2017โ‚น88.50 B504.65%
2016โ‚น14.63 B-65.71%
2015โ‚น42.68 B-35.88%
2014โ‚น66.57 B24.64%
2013โ‚น53.41 B205.92%
2012โ‚น17.45 B121.48%
2011โ‚น7.88 B-41.61%
2010โ‚น13.50 B9.24%
2009โ‚น12.35 B80.31%
2008โ‚น6.85 B-66.73%
2007โ‚น20.60 B101.1%
2006โ‚น10.24 B84.78%
2005โ‚น5.54 B-15.57%
2004โ‚น6.56 B5.66%
2003โ‚น6.21 B74.03%
2002โ‚น3.57 B-67.63%
2001โ‚น11.03 B-45.26%
2000โ‚น20.15 B

End of Day market cap according to different sources

On Dec 12th, 2025 the market cap of Sangamo Therapeutics was reported to be:

โ‚น13.66 Billion
by Nasdaq info icon info icon
โ‚น13.66 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Gilead Sciences
GILD
โ‚น13.483 T 98,559.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚น4.740 T 34,585.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น15.442 T 112,893.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚น2.305 T 16,767.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
โ‚น1.537 T 11,151.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚น46.007 T 336,546.55%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น924.33 B 6,663.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น22.610 T 165,349.43%๐Ÿ‡บ๐Ÿ‡ธ USA